JP Morgan Chase
SOPH icon

JP Morgan Chase’s SOPHiA GENETICS SOPH Stock Holding History

JP Morgan Chase’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-206
Closed -$1.04K – 8054
2026
Q1 		$966 Buy
+206
New +$1K ﹤0.01% 7125
2025
Q3 		– Sell
-198
Closed -$614 – 7702
2025
Q2 		$614 Buy
+198
New +$590 ﹤0.01% 6677
2024
Q1 		– Sell
-881
Closed -$4.15K – 7854
2023
Q4 		$4.15K Sell
881
-29,640
-97% -$111K ﹤0.01% 6588
2023
Q3 		$77.8K Sell
30,521
-5,603
-16% -$17.8K ﹤0.01% 5628
2023
Q2 		$162K Sell
36,124
-18,604
-34% -$84.1K ﹤0.01% 5200
2023
Q1 		$272K Buy
54,728
+23,336
+74% +$75.6K ﹤0.01% 4874
2022
Q4 		$65K Buy
31,392
+30,408
+3,090% +$68.3K ﹤0.01% 5520
2022
Q3 		$3K Buy
+984
New +$3.45K ﹤0.01% 6197
2022
Q1 		– Sell
-343
Closed -$5K – 6978
2021
Q4 		$5K Sell
343
-150
-30% -$2.21K ﹤0.01% 6425
2021
Q3 		$9K Buy
+493
New +$8.67K ﹤0.01% 6187

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

JP Morgan Chase's SOPH Position: Q2 2026 in Review

JP Morgan Chase sold out of SOPHiA GENETICS (SOPH) in Q2 2026, closing a stake of 206 shares — an estimated $1.04K sold.

JP Morgan Chase first reported a position in SOPH in Q3 2021 and held it in 10 quarters. The position peaked at $272K in Q1 2023. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • JP Morgan Chase reported no remaining SOPHiA GENETICS position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 206 SOPHiA GENETICS shares in Q2 2026, an estimated $1.04K.
  • JP Morgan Chase first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 10 quarters.
  • JP Morgan Chase's SOPHiA GENETICS position peaked at $272K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.